ID   BRO
AC   CVCL_7036
SY   Bro
DR   ChEMBL-Cells; CHEMBL3308611
DR   ChEMBL-Targets; CHEMBL614665
DR   PubChem_Cell_line; CVCL_7036
DR   Wikidata; Q54798305
RX   PubMed=1968359;
RX   PubMed=3965144;
CC   Population: Caucasian.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
RX   PubMed=1968359;
RA   Lincke C.R., van der Bliek A.M., Schuurhuis G.J.,
RA   van der Velde-Koerts T., Smit J.J.M., Borst P.;
RT   "Multidrug resistance phenotype of human BRO melanoma cells
RT   transfected with a wild-type human mdr1 complementary DNA.";
RL   Cancer Res. 50:1779-1785(1990).
//
RX   PubMed=3965144;
RA   Lockshin A., Giovanella B.C., De Ipolyi P.D., Williams L.J. Jr.,
RA   Mendoza J.T., Yim S.O., Stehlin J.S. Jr.;
RT   "Exceptional lethality for nude mice of cells derived from a primary
RT   human melanoma.";
RL   Cancer Res. 45:345-350(1985).
//